One-year survival following early revascularization for cardiogenic shock (SCHOCK trial).
D000328:Adult; D017677:Age Distribution; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D016001:Confidence Intervals; D001026:Coronary Artery Bypass / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality* / Q000601:surgery* / Q000628:therapy; D011336:Probability; D011379:Prognosis; D012720:Severity of Illness Index; D012770:Shock, Cardiogenic / Q000150:complications / Q000401:mortality* / Q000601:surgery* / Q000628:therapy; D016019:Survival Analysis; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome